Does OMAVELOXOLONE Cause Gait inability? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Gait inability have been filed in association with OMAVELOXOLONE (SKYCLARYS). This represents 0.5% of all adverse event reports for OMAVELOXOLONE.
6
Reports of Gait inability with OMAVELOXOLONE
0.5%
of all OMAVELOXOLONE reports
0
Deaths
1
Hospitalizations
How Dangerous Is Gait inability From OMAVELOXOLONE?
Of the 6 reports, 1 (16.7%) required hospitalization.
Is Gait inability Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OMAVELOXOLONE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does OMAVELOXOLONE Cause?
Fatigue (118)
Nausea (101)
Hepatic enzyme increased (100)
Product dose omission issue (92)
Headache (83)
Diarrhoea (77)
Blood cholesterol increased (67)
Muscle spasms (64)
Abdominal pain upper (51)
Atrial fibrillation (48)
What Other Drugs Cause Gait inability?
ADALIMUMAB (3,844)
ETANERCEPT (2,710)
METHOTREXATE (2,559)
TOFACITINIB (2,227)
SECUKINUMAB (2,216)
TOCILIZUMAB (2,139)
LEFLUNOMIDE (2,065)
RITUXIMAB (2,028)
ABATACEPT (2,019)
HYDROXYCHLOROQUINE (1,881)
Which OMAVELOXOLONE Alternatives Have Lower Gait inability Risk?
OMAVELOXOLONE vs OMBITASVIR
OMAVELOXOLONE vs OMBITASVIR\PARITAPREVIR\RITONAVIR
OMAVELOXOLONE vs OMEGA-3-ACID ETHYL ESTERS
OMAVELOXOLONE vs OMEGA-3-CARBOXYLIC ACIDS
OMAVELOXOLONE vs OMEGA-3 FATTY ACIDS